2025-01-01 04628689 2025-12-31 04628689 2025-01-01 2025-12-31 04628689 2024-12-31 04628689 2024-01-01 2024-12-31 04628689 uk-bus:Director1 2025-01-01 2025-12-31 iso4217:GBP xbrli:pure 04628689 uk-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 04628689 uk-bus:Micro-entities 2025-01-01 2025-12-31 04628689 uk-bus:FullAccounts 2025-01-01 2025-12-31 04628689 uk-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31

Vasogenics (Systems) Limited

Registered Number:04628689

For the year ended 31 December 2025
England and Wales
Unaudited Financial Statements

2
For the year ended 31 December 2025
Vasogenics (Systems) Limited
Contents Page
1
Statement of Financial Position and Notes to the Accounts
3

04628689

Registered Number :

As at 31 December 2025

Vasogenics (Systems) Limited
Statement of Financial Position and Notes to the Accounts

£

£

2024
2025

£

£

80,861
80,861

Current assets

80,861
80,861
Net current assets

Total assets less current liabilities

80,861
80,861
80,861
Net assets
80,861
80,861
80,861

Capital and reserves

Notes to the Accounts

Statutory Information

Vasogenics (Systems) Limited is a private limited company, limited by shares, domiciled in England and Wales,
registration number 04628689.

Registered address:

110 Skipton Road
Ilkley
LS299HE

The presentation currency is £ sterling.

1. Average number of persons employed

During the year the average number of employees was 1 (2024 : 1)

For the year ended 31 December 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

These financial statements have been prepared in accordance with the micro-entities provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Richard Doyle Director

These financial statements were approved and authorised for issue by the Board on 20 January 2026 and were signed by:

1 of 1